Bromocriptine and psychosis: A literature review
- Alan Boyd D.O.
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Bromocriptine is an ergot-derived dopamine agonist. Its current uses include the treatment of Parkinson's disease, postpartum ablaction, prolactionmas, acromegaly, and amenorrhea and galactorrhea secondary to neuroleptic use. It is often reported to produce psychiatric side effects such as confusion, hallucinations, and delusions. The literature is reviewed and supports a strong anecdotal relationship between bromocriptine use and psychosis.
- Bromocriptine and psychosis: A literature review
Volume 66, Issue 1 , pp 87-95
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Human Sciences Press
- Additional Links
- Alan Boyd D.O. (1)
- Author Affiliations
- 1. Tulane Medical Center, Department of Psychiatry and Neurology, Tulane University, 1430 Tulane Avenue, 70112-2699, New Orleans, Lousiana